Drug Shortage Report for JAMP-GABAPENTIN TABLETS
Report ID | 180232 |
Drug Identification Number | 02402289 |
Brand name | JAMP-GABAPENTIN TABLETS |
Common or Proper name | Gabapentin Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 600MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-12-09 |
Estimated end date | 2023-01-30 |
Actual end date | 2023-01-27 |
Shortage status | Resolved |
Updated date | 2023-01-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-01-31 | French | Compare |
v3 | 2023-01-31 | English | Compare |
v2 | 2023-01-09 | French | Compare |
v1 | 2023-01-09 | English | Compare |
Showing 1 to 4 of 4